| 000 | 03249nam a22003017a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20240305192527.0 | ||
| 008 | 220802b |||||||| |||| 00| 0 eng d | ||
| 020 | _a1592596614 | ||
| 020 | _a 9781592596614 | ||
| 040 | _cDLC | ||
| 050 | _aWT 155 A4756 2004 | ||
| 050 | _a RC523.A3748 2004 | ||
| 082 |
_221 _a616.8’31 RIC |
||
| 100 |
_aRalph W. Richter _941208 |
||
| 222 | _aabnormalities activity ADAScog Alzheimer disease Alzheimer’s disease AMPA AMPA receptor amyloid amyloid precursor protein apathy apolipoprotein Arch Neurol assessment associated behavioral brain caregiver cerebral changes cholinergic Clin clinical trials clinician cognitive function cortex deficits demented patients depression diagnosis differences differentiation disorders donepezil dose doubleblind drugs dysfunction effects efficacy elderly estrogen etal frontal frontotemporal dementia galantamine gene genetic Geriatr Psychiatry global growth factor hippocampal hNSC increased inhibitors inthe lesions levels Lewy bodies longterm markers measures memantine memory metabolism mice mild cognitive impairment MMSE mutations neurodegenerative neurofibrillary neurofibrillary tangles Neurology neurons neuroprotective neuropsychiatric symptoms neuropsychological Neurosci odor ofthe olfactory oxidative stress Parkinson’s disease pathology patients with Alzheimer’s placebo placebocontrolled plaques potential precursor protein predementia presenilin progressive receptor risk factors rivastigmine Scale score significant stem cells syndrome tacrine tau protein testosterone therapeutic therapy treatment vascular dementia | ||
| 245 |
_aAlzheimer’s Disease _b A Physician’s Guide to Practical Management _cCurrent Clinical Neurology |
||
| 250 | _aillustrated, reprint | ||
| 260 |
_aNew York _b Springer Science & Business Media _c2003 |
||
| 300 | _a 479 pages | ||
| 520 | _aAlzheimer’s disease (AD) is a devastating and dehumanizing illness affecting increasingly large numbers of elderly and even middle-aged persons in a worldwide epidemic. Alzheimer’s Disease: A Physician’s Guide to Practical Management was written by selected clinicians and scientists who represent some of the world’s leading centers of excellence in AD research. The editors are proud and grateful for their profound contributions. This book is particularly designed to assist physicians and other health-care professionals in the evaluation, assessment, and treatment of individuals with AD. At the same time, by illuminating the basic scientific background, we hope to provide state-of-the art information about the disease and possible future therapeutic strategies. The recent psychiatric treatment aspects of AD are also clearly presented. Because the early diagnosis of the dementia process is now considered of increasing importance, we focus particularly in several chapters on early changes and preclinical conditions, such as mild cognitive impairment and predementia AD. | ||
| 600 |
_xAlzheimer Disease. _941209 |
||
| 600 |
_xMedical › Neurology _927053 |
||
| 600 |
_xMedical / Clinical Medicine _926816 |
||
| 600 |
_xMedical / Neurology _926948 |
||
| 700 |
_a Brigitte Zoeller Richter _941210 |
||
| 942 |
_2ddc _cEB |
||
| 999 |
_c8043 _d8043 |
||